Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-01-04
1995-05-09
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514214, 514305, 514362, 514364, 546112, 546133, 546137, 540461, 540477, 540582, 540584, C07D41714, C07D41314, C07D45302, C07D52100
Patent
active
054140099
ABSTRACT:
The present invention relates to compounds ##STR1## where G is ##STR2## and Z is oxygen or sulfur and the remaining variables are as defined in the Specification. The compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
REFERENCES:
patent: 5041455 (1991-08-01), Sauerberg et al.
patent: 5043345 (1991-08-01), Sauerberg et al.
patent: 5260314 (1993-11-01), Sauerberg
Dwan, P. J. and Rees, C. W. J. Chem Soc. Perkin Traus 1 (12) (1989) pp. 2489-2494.
Olesen Preben H.
Sauerberg Per
Huang Evelyn
Ivy C. Warren
Lambiris Elias J.
Novo Nordisk A S
Zelson Steve T.
LandOfFree
Azabicyclo substituted oxa- or thia-diazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azabicyclo substituted oxa- or thia-diazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicyclo substituted oxa- or thia-diazole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1705567